Wins $30,000 first place prize among >150 amazing startups in CA event held April 7th at Stanford Medical school. Sponsored by BioSciKin, a Chinese biotech venture focused on precision medicine.
See full article at http://califesciences.org/bioscikin-1/.
Fibralign has developed and established an end-to-end manufacturing system for production of its BioBridge Collagen Matrix in its GMP facility located in Union City, California.
Fibralign hosted the Lymphedema Summit on January 23, 2022, an international research seminar focused on “Advancements in Lymphedema Surgical Treatment.” This special event featured a gathering of the leading surgeons and researchers in this field and took...
NCI-funded study evaluating Fibralign’s BioBridge® as an adjunct to microsurgical treatment SAN FRANCISCO, June 10, 2021 /PRNewswire/ -- The UCSF Rosenman Institute is proud to announce the 2021 cohort of the Rosenman Innovators, a group of early-stage health...
NCI-funded study evaluating Fibralign’s BioBridge® as an adjunct to microsurgical treatment April 14, 2021 – The University of Chicago Medicine has announced today that it is now enrolling patients into LymphBridge™, a randomized clinical study to evaluate a...